0
Articles |

Retreatment Tuberculosis Cases : Factors Associated With Drug Resistance and Adverse Outcomes FREE TO VIEW

Afranio L. Kritski; Luis Sergio Rodrigues de Jesus; Monica K. Andrade; Eduardo Werneck-Barroso; Maria Armanda Monteiro S. Vieira; Alice Hoffner; Lee W. Riley
Author and Funding Information

Affiliations: From the Servico de Pneumologia, Hospital Clementino Fraga Filho, da Universidade Federal do Rio de Janeiro, Brazil,  From the Instituto de Tisiologia e Pneumologia, da Universidade Federal do Rio de Janeiro, Brazil,  From the Division of International Medicine and Infectious Diseases, Cornell University Medical College, New York

Affiliations: From the Servico de Pneumologia, Hospital Clementino Fraga Filho, da Universidade Federal do Rio de Janeiro, Brazil,  From the Instituto de Tisiologia e Pneumologia, da Universidade Federal do Rio de Janeiro, Brazil,  From the Division of International Medicine and Infectious Diseases, Cornell University Medical College, New York

Affiliations: From the Servico de Pneumologia, Hospital Clementino Fraga Filho, da Universidade Federal do Rio de Janeiro, Brazil,  From the Instituto de Tisiologia e Pneumologia, da Universidade Federal do Rio de Janeiro, Brazil,  From the Division of International Medicine and Infectious Diseases, Cornell University Medical College, New York


1997 by the American College of Chest Physicians


Chest. 1997;111(5):1162-1167. doi:10.1378/chest.111.5.1162
Text Size: A A A
Published online

Abstract

Study objective: Risk factors associated with treatment failure and multidrug-resistant tuberculosis (MDR-TB) were examined among HIV-seronegative patients who were previously treated for tuberculosis (TB).

Design: Prospective, cohort study of patients referred to the study hospital for retreatment of TB between March 1986 and March 1990.

Patients: The patients belonged to three groups, according to outcomes following their previous treatment: 37 patients who abandoned treatment or suffered relapse after completion of therapy (group A), 91 patients who failed to respond to the first-line drug regimen (group B), and 78 patients who failed to respond to the second-line drug regimen (group C).

Results: Patients with Mycobacterium tuberculosis strains resistant to rifampin and isoniazid were found in 2 (6%) in group A, 29 (33%) in group B, and 49 (65%) in group C. Cure was achieved in 77% in group A, 54% in group B, and 36% in group C. Death occurred in none of the patients in group A, 8% in group B, and 24% in group C. In a multivariate logistic regression analysis, unfavorable response (failure to sterilize sputum culture, death, and abandonment) was significantly associated with infection with a multidrug-resistant M tuberculosis strain (p=0.0002), cavitary disease (p=0.0029), or irregular use of medications (p<0.0001).

Conclusion: These observations show that a previous treatment outcome and current clinical and epidemiologic histories can be used to predict the development of MDR-TB and adverse outcomes in patients undergoing retreatment for TB. Such information may be useful for identifying appropriate patient candidates for programs such as directly observed therapy.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Pleural Tuberculosis in the United States*: Incidence and Drug Resistance
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543